IL7R and colitis: Given our results successfully treating Hb-induced colitis in Mdr1a−/− mice by inhibiting IL-7R signaling, we determined whether non-lymphoid cells also respond to anti-IL-7Rα treatment as was suggested in the mRNA and protein analysis.